The syndrome that disrupts the metabolism of millions of women
Polycystic ovary syndrome (PCOS) is being renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to reflect its status as a multi-system metabolic disorder rather than a strictly gynecological condition. The change, announced at the European Congress of Endocrinology in Prague, follows a decade of research and international consultations involving 22,000 participants, including clinicians and patients, to better address symptoms like insulin resistance, obesity, and diabetes.
Did You Know? The decision to rename the condition follows years of consensus building among 22,000 participants, who argued that the term “PCOS” led to a misleading clinical focus on ovarian cysts rather than the systemic endocrine and metabolic nature of the disease.
Why the name change matters
The transition to the name PMOS represents a shift in medical philosophy. According to lead researcher Professor Helena Teede of Monash University, the previous name reduced a complex, long-term endocrine disorder to a misunderstanding regarding cysts. By reframing the condition, medical professionals aim to move away from an exclusive focus on the ovaries and toward a broader clinical picture that addresses the root causes of symptoms such as acne, excess hair growth, and metabolic dysfunction.
Dr. Galina Shenkerman, a specialist in internal medicine and endocrinology at MEDBALANCE, notes that the condition involves follicles failing to mature due to a hormonal imbalance—specifically a deficiency in female hormones and an increase in male hormones. This hormonal shift creates a ripple effect, driving insulin resistance, weight gain, and an increased risk of type 2 diabetes. For many patients, the metabolic complications are as significant as the reproductive challenges.
Diagnostic and treatment expectations
While the name is changing, the diagnostic process will not shift immediately. According to the World Health Organization, implementation into daily medical practice is expected to take up to three years to allow for updates in disease classification, staff training, and international translation. During this period, clinicians are encouraged to broaden their diagnostic criteria beyond menstrual irregularities to include screenings for insulin levels and fat metabolism disorders.
Expert Insight: The shift toward a metabolic-first approach likely signals a major change in how insurance systems and hospital protocols categorize patient care. By addressing insulin resistance as a primary driver, doctors may be able to intervene earlier in a patient’s life to prevent the long-term progression toward type 2 diabetes.
Managing the condition through lifestyle
Because insulin resistance acts as a central driver for weight gain and symptom severity, lifestyle management is central to treatment. High insulin levels can increase cravings for carbohydrates and stimulate fat storage while preventing fat breakdown. To combat this, experts recommend a diet that prioritizes whole carbohydrates, such as legumes and quinoa, and utilizes a “protein window” to keep insulin levels low. Regular physical activity, incorporating both aerobic and strength training, is also critical for improving insulin sensitivity and reducing body fat.
Frequently Asked Questions
Why is the name being changed to PMOS?
The name was changed because international experts and patients agreed that “PCOS” was misleading and focused too heavily on the ovaries, failing to reflect the condition’s status as a complex, multi-system metabolic disorder.
How does PMOS affect weight gain?
In PMOS, the pancreas secretes excessive insulin due to insulin resistance. This high insulin level blocks fat breakdown and increases cravings for carbohydrates, creating a cycle that makes weight loss difficult without targeted dietary and physical interventions.
When will these changes be reflected in medical offices?
According to the World Health Organization, the transition will be implemented in daily clinical practice within three years to allow for necessary updates to administrative systems and medical training.
How might these new diagnostic standards change the way you approach your own long-term health goals?